| |
| |
|
| Insider
Information: |
Reynolds Francis |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,045,920 |
|
|
Indirect Shares
|
23,488 |
|
|
| Direct
Value |
$3,437,450 |
|
|
|
Indirect Value
|
$8,925 |
|
|
| Total
Shares |
9,069,408 |
|
|
| Total
Value |
$3,446,375 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Invivo Therapeutics Holdings Cor... |
NVIV |
10% Owner |
2014-05-09 |
9,045,920 |
2014-05-09 |
23,488 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVIV |
Invivo Therapeutics Holdi... |
Chief Executive OfficerOfficer |
• • • |
2010-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,147,660 |
|
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2011-11-29 |
4 |
S |
$2.52 |
$239,020 |
D/D |
(95,000) |
14,909,160 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2011-12-28 |
4 |
S |
$2.74 |
$392,645 |
D/D |
(143,500) |
15,004,160 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-01-04 |
4 |
S |
$2.62 |
$116,791 |
D/D |
(44,497) |
14,853,163 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-01-05 |
4 |
S |
$2.63 |
$286,779 |
D/D |
(109,000) |
14,744,163 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-01-06 |
4 |
S |
$2.53 |
$244,375 |
D/D |
(96,503) |
14,647,660 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-06 |
4 |
AS |
$1.65 |
$7,018 |
D/D |
(4,250) |
14,373,410 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-07 |
4 |
AS |
$1.67 |
$7,163 |
D/D |
(4,250) |
14,369,160 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-10 |
4 |
AS |
$1.66 |
$7,058 |
D/D |
(4,250) |
14,364,910 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-11 |
4 |
AS |
$1.67 |
$7,146 |
D/D |
(4,250) |
14,360,660 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-12 |
4 |
AS |
$1.61 |
$7,012 |
D/D |
(4,250) |
14,356,410 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-13 |
4 |
AS |
$1.60 |
$6,800 |
D/D |
(4,250) |
14,352,160 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-14 |
4 |
AS |
$1.60 |
$7,073 |
D/D |
(4,250) |
14,347,910 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-17 |
4 |
AS |
$1.60 |
$6,830 |
D/D |
(4,250) |
14,343,660 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-18 |
4 |
AS |
$1.61 |
$6,908 |
D/D |
(4,250) |
14,339,410 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-21 |
4 |
AS |
$1.62 |
$6,890 |
D/D |
(4,250) |
14,326,660 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-24 |
4 |
AS |
$1.63 |
$6,950 |
D/D |
(4,250) |
14,322,410 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-26 |
4 |
AS |
$1.65 |
$7,013 |
D/D |
(4,250) |
14,318,160 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-27 |
4 |
AS |
$1.80 |
$7,650 |
D/D |
(4,250) |
14,313,910 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-28 |
4 |
AS |
$1.82 |
$7,793 |
D/D |
(4,250) |
14,309,660 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2012-12-31 |
4 |
AS |
$1.80 |
$7,730 |
D/D |
(4,250) |
14,305,410 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-01-02 |
4 |
AS |
$1.77 |
$7,569 |
D/D |
(4,250) |
14,301,160 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-01-03 |
4 |
AS |
$1.85 |
$7,900 |
D/D |
(4,250) |
14,296,910 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-01-04 |
4 |
AS |
$1.75 |
$7,438 |
D/D |
(4,250) |
14,292,660 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-01-07 |
4 |
AS |
$1.90 |
$8,210 |
D/D |
(4,250) |
14,288,410 |
0 |
- |
|
360 Records found
|
|
Page 1 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
